New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 15, 2014
11:45 EDTACEACE Limited raises annual dividend 3% to $2.60 per share
ACE Limited announced that its shareholders have approved all matters submitted to the ACE Limited 2014 Annual General Meeting, held at the company’s offices in Zurich, Switzerland, including a 3% increase to the company’s quarterly dividend to $2.60 annually, or 65c per quarter per share. This increase follows a 24% increase in the quarterly dividend that was approved by shareholders on January 10. The dividend distribution will be in the form of a par value reduction payable in four installments. The amount of each installment in Swiss francs will be adjusted up or down to equal 65c near the time of payment, subject to an aggregate cap for the four installments of CHF 3.42 per share. In addition, the Board of Directors declared that shareholders of record at the close of business on July 23, will be entitled to payment of the first of such installments, subject to a required filing with the Swiss Commercial Register. This dividend payment will be made in U.S. dollars on August 13, by the company’s transfer agent. The company’s par value is currently CHF 26.59 per share, and in connection with the dividend installment, the par value per share will be reduced by the CHF equivalent of 65c based on the USD/CHF rate published on July 16.
News For ACE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 23, 2015
06:30 EDTACEACE Limited launches enhanced clinical trials cover for UK companies
ACE Group announced the launch of an enhanced clinical trials liability proposition, which provides life science companies with specialist insurance for clinical trials programmes conducted anywhere in the world, as part of its continued strategy to build dedicated liability insurance solutions for the UK’s fastest growing industries. The program include flexible capacity of up to $75 aggregated limit per investigational product.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use